Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis

摘要

Background An updated bioscore has been proposed within the context of the 8th edition American Joint Committee on Cancer (AJCC) staging system for breast cancer. This study seeks to validate the discriminating value of this bioscore among non-metastatic breast cancer patients registered within the surveillance, epidemiology, and end results (SEER) database.